Shanghai MicroPort Medical (Group) Co., Ltd.

1661 Zhangdong Rd., ZJ Hi-Tech Park, Pilot Free Trade Zone, Shanghai, China

Clinical Trials

5 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Not Applicable

83.3%

Phase 4

12.5%

Trial Status Distribution

Active, not recruiting

16.7%

Completed

37.5%

Not yet recruiting

4.2%

Recruiting

12.5%

Unknown

29.2%

Clinical Trials

Trials sponsored by this organization (24)

A Trial of DCB vs DES in the Treatment of de Novo Large Diameter Coronary Atherosclerotic Stenosis(LARGE ONE)

Not Applicable

Recruiting

interventional

Dec 2022134 participants

TARGET-PREMIER Trail in Evaluating the Safety and Efficacy of the Rapamycin Target Eluting Stent in CAS Treatment

Not Applicable

Active, not recruiting

interventional

Feb 2022200 participants

Using Left Atrium Appendage Closure in NVAF Patients With High Risk of Ischemic Stroke

Not Applicable

Active, not recruiting

interventional

Mar 2021210 participants

Compare Sirolimus Coated Balloon Catheter With Paclitaxel Coated Balloon Catheter in De Novo Coronary Bifurcated Lesions

Not Applicable

Active, not recruiting

interventional

Feb 2021236 participants

Firehawk Rapamycin Target Eluting Coronary Stent North American Trial

Not Applicable

Active, not recruiting

interventional

Feb 20211,720 participants

Safety and Efficacy of Rotator Cuff Function Restoration Balloon in Irreparable Rotator Cuff Tear

Not Applicable

Unknown

interventional

Sep 2020112 participants

Trial for MicroPort's DCB

Not Applicable

Not yet recruiting

interventional

Sep 2020216 participants

OCT vs IVUS vs QCA to Guide Moderate-to-severe Calcified Lesion Stent Implantation

Not Applicable

Recruiting

interventional

Oct 2019375 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations